163 related articles for article (PubMed ID: 11781637)
1. Intraoral psoralen ultraviolet A irradiation (PUVA) treatment of refractory oral chronic graft-versus-host disease following allogeneic stem cell transplantation.
Menillo SA; Goldberg SL; McKiernan P; Pecora AL
Bone Marrow Transplant; 2001 Oct; 28(8):807-8. PubMed ID: 11781637
[No Abstract] [Full Text] [Related]
2. Management of graft-versus-host disease.
Arai S; Vogelsang GB
Blood Rev; 2000 Dec; 14(4):190-204. PubMed ID: 11124107
[TBL] [Abstract][Full Text] [Related]
3. Treatment of oral chronic graft-versus-host disease with PUVA therapy: case report and literature review.
Redding SW; Callander NS; Haveman CW; Leonard DL
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Aug; 86(2):183-7. PubMed ID: 9720094
[TBL] [Abstract][Full Text] [Related]
4. Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporine and tacrolimus.
Dvorak CC; Callard E; Agarwal R
Bone Marrow Transplant; 2006 Aug; 38(3):253-4. PubMed ID: 16785867
[No Abstract] [Full Text] [Related]
5. Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Hattori K; Doki N; Kurosawa S; Hino Y; Yamamoto K; Sakaguchi M; Harada K; Ikegawa S; Shingai N; Senoo Y; Igarashi A; Najima Y; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
Ann Hematol; 2017 Feb; 96(2):319-321. PubMed ID: 27766393
[No Abstract] [Full Text] [Related]
6. Use of infliximab-daclizumab combination for the treatment of acute and chronic graft-versus-host disease of the liver and gut.
Rodriguez V; Anderson PM; Trotz BA; Arndt CA; Allen JA; Khan SP
Pediatr Blood Cancer; 2007 Aug; 49(2):212-5. PubMed ID: 16261610
[TBL] [Abstract][Full Text] [Related]
7. Psoralen plus ultraviolet-A-bath photochemotherapy as an adjunct treatment modality in cutaneous chronic graft versus host disease.
Leiter U; Kaskel P; Krähn G; Gottlöber P; Bunjes D; Peter RU; Kerscher M
Photodermatol Photoimmunol Photomed; 2002 Aug; 18(4):183-90. PubMed ID: 12390673
[TBL] [Abstract][Full Text] [Related]
8. Response to mycophenolate mofetil therapy in refractory chronic graft-versus-host disease.
Busca A; Locatelli F; Marmont F; Audisio E; Falda M
Haematologica; 2003 Jul; 88(7):837-9. PubMed ID: 12857569
[No Abstract] [Full Text] [Related]
9. [Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation].
Wang J; Song X; Zhang W; Tong S; Hou J; Chen L; Lou J; Li H; Ding X; Min B
Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(8):507-10. PubMed ID: 12133492
[TBL] [Abstract][Full Text] [Related]
10. [Graft vs. tumor effect in chronic granulocytic leukemia].
Ruiz-Argüelles GJ
Rev Invest Clin; 2002; 54(2):154-60. PubMed ID: 12053814
[No Abstract] [Full Text] [Related]
11. Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease.
Furlong T; Leisenring W; Storb R; Anasetti C; Appelbaum FR; Carpenter PA; Deeg HJ; Doney K; Kiem HP; Nash RA; Sanders JE; Witherspoon R; Thompson D; Martin PJ
Biol Blood Marrow Transplant; 2002; 8(4):206-12. PubMed ID: 12014809
[TBL] [Abstract][Full Text] [Related]
12. Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect.
Feinstein L; Sandmaier B; Maloney D; McSweeney PA; Maris M; Flowers C; Radich J; Little MT; Nash RA; Chauncey T; Woolfrey A; Georges G; Kiem HP; Zaucha JM; Blume KG; Shizuru J; Niederwieser D; Storb R
Ann N Y Acad Sci; 2001 Jun; 938():328-37; discussion 337-9. PubMed ID: 11458521
[TBL] [Abstract][Full Text] [Related]
13. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus.
Eckardt A; Starke O; Stadler M; Reuter C; Hertenstein B
Oral Oncol; 2004 Sep; 40(8):811-4. PubMed ID: 15288836
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute graft-versus-host disease with PUVA (psoralen and ultraviolet irradiation): results of a pilot study.
Wiesmann A; Weller A; Lischka G; Klingebiel T; Kanz L; Einsele H
Bone Marrow Transplant; 1999 Jan; 23(2):151-5. PubMed ID: 10197800
[TBL] [Abstract][Full Text] [Related]
15. A Case of Nephrotic Syndrome after Allogeneic Stem Cell Transplantation.
Hogan JJ
Clin J Am Soc Nephrol; 2020 Jun; 15(6):873-875. PubMed ID: 32144100
[No Abstract] [Full Text] [Related]
16. Therapeutic efficacy of azathioprine in addition to prednisone-based regimens as first-line chronic graft-versus-host disease treatment.
Uhm J; Shin E; Michelis FV; Thyagu S; Viswabandya A; Lipton JH; Messner HA; Kim DDH
Bone Marrow Transplant; 2018 Mar; 53(3):334-338. PubMed ID: 29247219
[No Abstract] [Full Text] [Related]
17. Amelioration of steroid-resistant chronic graft-versus-host-mediated liver disease via tacrolimus treatment.
Nagler A; Menachem Y; Ilan Y
J Hematother Stem Cell Res; 2001 Jun; 10(3):411-7. PubMed ID: 11454316
[TBL] [Abstract][Full Text] [Related]
18. Maximizing the benefits of mycophenolate mofetil as graft-versus-host disease prophylaxis.
Hamilton BK; Kalaycio M
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1869-70. PubMed ID: 25065905
[No Abstract] [Full Text] [Related]
19. Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation.
Lorillon G; Robin M; Meignin V; Ribaud P; Lescoeur B; Gossot D; Socié G; Tazi A; Bergeron A
Eur Respir J; 2011 Aug; 38(2):470-2. PubMed ID: 21804164
[No Abstract] [Full Text] [Related]
20. Long-term extracorporeal photochemotherapy in a pediatric patient with refractory sclerodermatous chronic graft-versus-host disease.
Bisaccia E; Palangio M; Gonzalez J
Transfus Apher Sci; 2011 Oct; 45(2):187-90. PubMed ID: 21890415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
